Back to search results

Project CONTINUITY: Improving Cervical Cancer Screening for Underserved Women

This study, called Project CONTINUITY, is looking at ways to help women get and stay on track with their cervical cancer screenings. It's for women aged 25 to 65 who have not had cervical cancer or a hysterectomy. You'll have a choice between an HPV self-test (a test you can do yourself at home) or a standard Pap test in a clinic. Researchers want to see how well women follow through with these screening steps over 6 months. The study also involves answering questions about your cancer history and what you know about preventing cervical cancer.

Study design
This is an observational study planning to enroll 800 women. It compares two different ways to get cervical cancer screening.
What's involved
You would choose between an HPV self-test or an in-clinic Pap test, and answer questions about your cancer history and knowledge of cervical cancer prevention.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 6 months to see how well they adhere to cervical cancer screening steps.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05390567

Project CONTINUITY: Promoting Evidence-Based Cancer Screening Among Underserved Women

Recruiting
Not specifiedAges 25–65Observational
University of Florida
~800 participants
Updated 2026-08-06 on ClinicalTrials.gov
What's tested:Participant Choice of HPV Self-TestSurvey: Participant cancer history and cervical cancer prevention/screening knowledgeParticipant Choice of Standard of Care in-clinic Pap-test

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adherence to steps in the cervical cancer screening continuum
Measured over 6 months

Conditions

Cervical Cancer Screening Methods

Explore related trials

Cervical Carcinoma

Where it's being run

1 sites across 1 states
Florida1

Study leadership

  • Ramzi A Salloum, PhD · PRINCIPAL_INVESTIGATOR · Division Director, Department of Health Outcomes and Biomedical Informatics, University of Florida; Associate Director, Office of Community Outreach and Engagement, UFHealth Cancer Center

Who to contact

Jamie Barrow, MHA, CCRP
[email protected]
352-3253703
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

For patients who are excluded for criterion 6, 7, and 8, the outreach team (community clinical navigator and CHW) will ask the participant if they can be re-contacted for potential future study eligibility assessment. If the participant agrees, the navigator or CHW will collect contact information to re-contact the participant at a later (pre-determined) date up to 20 weeks later for eligibility screening.

What this trial measures

  • Adherence to steps in the cervical cancer screening continuum6 months

    For the HPV self-testing group, 1. HPV test returned (Yes or No) 2. Results obtained (Yes or No) 3. Follow-up Pap test completed among those who tested positive for HPV (Yes or No) 4. Follow-up colposcopy completed among those who had positive Pap test (Yes or No) For the in-clinic testing group, 1\. In-clinic Pap test completed (Yes or No) 2. Results Obtained (Yes or No) 3. Follow-up colposcopy completed among those who had positive Pap test (Yes or No)